KERYX BIOPHARMACEUTICALS INC Increase (Decrease) in Deferred Revenue
KERYX BIOPHARMACEUTICALS INC reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-02-21
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2016 was -$3.53M, a 213.30% decline from fiscal 2015.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2015 was $3.11M, a 651.69% increase from fiscal 2014.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in deferred revenue for fiscal 2014 was $414.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | $0.00 derived: sum of 3 quarters · filed 2018-02-21 | $0.00 10-K · filed 2018-02-21 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $0.00 10-Q · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-21 | -$3.36M derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | -$3.36M derived: sum of 3 quarters · filed 2018-02-21 | -$3.72M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$3.36M derived: sum of 2 quarters · filed 2018-02-21 | -$3.72M derived: sum of 3 quarters · filed 2018-02-21 | -$3.53M 10-K · filed 2018-02-21 |
| 2016-09-30 | -$3.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.72M derived: sum of 2 quarters · filed 2017-11-07 | -$3.53M 10-Q · filed 2017-11-07 | -$1.99M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$168.00K 10-Q · filed 2017-07-27 | $1.37M derived: sum of 3 quarters · filed 2018-02-21 | $1.83M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $192.00K 10-Q · filed 2017-05-04 | $1.73M derived: sum of 2 quarters · filed 2018-02-21 | $2.19M derived: sum of 3 quarters · filed 2018-02-21 | $3.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $2.00M derived: sum of 2 quarters · filed 2018-02-21 | $2.81M derived: sum of 3 quarters · filed 2018-02-21 | $3.11M 10-K · filed 2018-02-21 |
| 2015-09-30 | $456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.27M derived: sum of 2 quarters · filed 2016-11-09 | $1.57M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $815.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.11M 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $300.00K 10-Q · filed 2016-04-28 | |||
| 2014-12-31 | $414.00K 10-K · filed 2017-03-01 | |||
| 2009-12-31 | -$18.62M 10-K · filed 2012-03-02 |